TIAP
Toronto, Ontariotiap.ca
Overview
TIAP specializes in venture building of early-stage health science technologies emerging from its academic members. It transforms early-stage scientific innovations into business ventures, de-risks ideas through expert financial and scientific advice, invests in early-stage innovations and sources external venture capital for future funding, and leverages its extensive global and local network to create links between industry, researchers, investors and Members.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Synakis | May 2026 | Pre Seed | Lead |
| NanoMorphix | May 2025 | Accelerator | Co-investor |
| Grey Matter Neurosciences | Dec 2024 | Seed | Co-investor |
| Radiant Biotherapeutics | Sep 2024 | Series A | Co-investor |
| HDAX Therapeutics | Sep 2024 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.